Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0006-2952(95)00137-o | DOI Listing |
Biochem Pharmacol
March 2007
Department of Cell Physiology & Pharmacology, University of Leicester, Henry Wellcome Building, Lancaster Road, Leicester LE1 9HN, UK.
A central dogma of G protein-coupled receptor (GPCR) pharmacology has been the concept that unlike agonists, antagonist ligands display equivalent affinities for a given receptor, regardless of the cellular environment in which the affinity is assayed. Indeed, the widespread use of antagonist pharmacology in the classification of receptor expression profiles in vivo has relied upon this 'antagonist assumption'. However, emerging evidence suggests that the same gene-product may exhibit different antagonist pharmacological profiles, depending upon the cellular context in which it is expressed-so-called 'phenotypic' profiles.
View Article and Find Full Text PDFBiochem Pharmacol
June 1995
Department of Cellular Biochemistry, Glaxo Research Institute, Research Triangle Park, NC 27709, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!